• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的全国性研究中小肠神经内分泌肿瘤患者的发病率和预后。

Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.

机构信息

Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Pathology, Landspitali University Hospital of Iceland, Reykjavik, Iceland.

出版信息

Cancer Epidemiol. 2022 Aug;79:102197. doi: 10.1016/j.canep.2022.102197. Epub 2022 Jun 16.

DOI:10.1016/j.canep.2022.102197
PMID:35716441
Abstract

BACKGROUND & AIMS: Small intestinal neuroendocrine tumours (SI-NETs) are the most frequent malignant tumours of the small intestine. Population based studies on SI-NETs are scarce. We aimed to examine the incidence, presentation of disease and prognosis of SI-NET and to determine patient prognosis in those undergoing emergency or elective surgery.

METHODS

This was a retrospective population-based study. Information on all patients diagnosed with neuroendocrine tumours of the small intestine (excluding duodenum) from the beginning of the Icelandic Cancer Registry and the pathology departments in the country (1966-2017). Detailed phenotypic information was obtained from medical records on symptoms at diagnosis, treatment, recurrence and survival.

RESULTS

A total of 113 patients with SI-NETs were identified, 3 patients were excluded due to lack of data and/or diagnostic error, leaving 110 patients for final analysis. The incidence of SI-NET was 0.78/100,000 and did not increase during the study period. A total of 42 % (n = 46) of patients were diagnosed incidentally. Long-term prognosis, after a landmark of 12 months, was better in patients who were diagnosed incidentally (HR 0.52; p = 0.03). Overall 89 % (n = 98) of cases underwent surgical resection of the primary tumor, 31 % (n = 30) patients acute or semi-acute surgery and 69 % (n = 68) elective surgery. Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery (HR: 5.99; p = 0.01) and associated with more severe surgical complications. However, there was no difference in the long-term risk of death after the first 12 months (HR: 1.39; p = 0.27).

CONCLUSIONS

The incidence of SI-NETs has not changed significantly in the last decades. Incidentally diagnosed SI-NET was associated with a favorable long-term prognosis. Emergency surgery in patients with SI-NET was associated with a significantly worse short-term risk of mortality compared to those who underwent elective surgery.

摘要

背景与目的

小肠类癌(SI-NETs)是小肠最常见的恶性肿瘤。基于人群的 SI-NET 研究很少。我们旨在研究 SI-NET 的发病率、疾病表现和预后,并确定接受急诊或择期手术的患者的预后。

方法

这是一项回顾性基于人群的研究。从冰岛癌症登记处和全国病理科(1966-2017 年)开始,获取所有诊断为小肠神经内分泌肿瘤(不包括十二指肠)的患者信息。详细的表型信息来自于病历中的诊断时症状、治疗、复发和生存情况。

结果

共确定了 113 例 SI-NET 患者,由于数据缺失和/或诊断错误,有 3 例被排除,最终有 110 例患者进行了最终分析。SI-NET 的发病率为 0.78/100,000,在研究期间没有增加。42%(n=46)的患者为偶然诊断。在 12 个月的时间点后,偶然诊断的患者具有更好的长期预后(HR 0.52;p=0.03)。总体上,89%(n=98)的病例接受了原发性肿瘤的手术切除,31%(n=30)患者接受了急性或半急性手术,69%(n=68)患者接受了择期手术。急诊手术与术后 12 个月内死亡风险增加 6 倍相关(HR:5.99;p=0.01),并与更严重的手术并发症相关。然而,在术后 12 个月后,死亡风险无差异(HR:1.39;p=0.27)。

结论

在过去几十年中,SI-NET 的发病率没有明显变化。偶然诊断的 SI-NET 与良好的长期预后相关。与择期手术相比,SI-NET 患者的急诊手术与短期死亡率显著增加相关。

相似文献

1
Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.基于人群的全国性研究中小肠神经内分泌肿瘤患者的发病率和预后。
Cancer Epidemiol. 2022 Aug;79:102197. doi: 10.1016/j.canep.2022.102197. Epub 2022 Jun 16.
2
Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.在一家转诊医院接受手术治疗的小肠类癌患者的生存和疾病复发情况。
Surg Oncol. 2020 Dec;35:336-343. doi: 10.1016/j.suronc.2020.09.015. Epub 2020 Sep 18.
3
The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors.术前症状对小肠神经内分泌肿瘤患者死亡的影响
Ann Surg Oncol. 2017 May;24(5):1214-1220. doi: 10.1245/s10434-016-5703-4. Epub 2016 Nov 30.
4
[Neuroendocrine tumors of the small bowels are on the rise: early tumors and their management].[小肠神经内分泌肿瘤呈上升趋势:早期肿瘤及其管理]
Z Gastroenterol. 2010 Mar;48(3):406-13. doi: 10.1055/s-0028-1109862. Epub 2010 Feb 24.
5
Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.小肠神经内分泌肿瘤中淋巴结转移的预后意义
Neuroendocrinology. 2015;101(1):58-65. doi: 10.1159/000371807. Epub 2015 Jan 5.
6
Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015.2001-2015 年澳大利亚昆士兰州小肠神经内分泌肿瘤的发病率、生存率和诊断时的分期。
Asia Pac J Clin Oncol. 2021 Aug;17(4):350-358. doi: 10.1111/ajco.13503. Epub 2021 Feb 10.
7
Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.预防性手术治疗 IV 期小肠神经内分泌肿瘤与生存的关系。
JAMA Oncol. 2018 Feb 1;4(2):183-189. doi: 10.1001/jamaoncol.2017.3326.
8
Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis.原发性肿瘤姑息性切除在晚期胰腺和小肠神经内分泌肿瘤中的作用:一项系统评价和荟萃分析
Eur J Surg Oncol. 2017 Oct;43(10):1808-1815. doi: 10.1016/j.ejso.2017.05.016. Epub 2017 May 25.
9
Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.胃肠胰神经内分泌肿瘤的腹膜转移:发病率、危险因素及预后
Ann Surg Oncol. 2017 Aug;24(8):2199-2205. doi: 10.1245/s10434-016-5734-x. Epub 2017 Feb 15.
10
A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.对3911例小肠神经内分泌肿瘤的三十年分析:进展缓慢。
Am J Gastroenterol. 2007 Jul;102(7):1464-73. doi: 10.1111/j.1572-0241.2007.01185.x. Epub 2007 Mar 27.

引用本文的文献

1
Prognostic impact of acute symptoms requiring surgery in patients with small-bowel neuroendocrine tumors.小肠神经内分泌肿瘤患者中需要手术治疗的急性症状的预后影响
Updates Surg. 2025 Aug 14. doi: 10.1007/s13304-025-02338-3.
2
Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective.神经内分泌肿瘤的流行病学见解与生存模式:地域视角
Endocr Oncol. 2025 Aug 5;5(1):e250039. doi: 10.1530/EO-25-0039. eCollection 2025 Jan.
3
Results of Surgical Reintervention After Suboptimal Initial Resection for Locoregional Neuroendocrine Tumors of the Small Intestine.
小肠局部区域神经内分泌肿瘤初次切除不充分后的手术再次干预结果
World J Surg. 2025 May;49(5):1343-1350. doi: 10.1002/wjs.12582. Epub 2025 Apr 16.
4
The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors.重复5-羟吲哚乙酸测量作为类癌性心脏病预测指标的价值:一项针对小肠神经内分泌肿瘤患者的前瞻性5年随访研究。
Cancers (Basel). 2024 Nov 21;16(23):3896. doi: 10.3390/cancers16233896.
5
Obstructive Jaundice Caused by Metastatic Neuroendocrine Tumor of the Ampulla of Vater in a Young Adult: A Case Report.青年成人 Vater 壶腹转移性神经内分泌肿瘤所致梗阻性黄疸:一例报告
Case Rep Gastroenterol. 2024 Apr 8;18(1):204-213. doi: 10.1159/000538260. eCollection 2024 Jan-Dec.
6
Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors.手术作为原发性小肠神经内分泌肿瘤切除的原则和技术考虑因素。
Ann Surg Oncol. 2024 Feb;31(2):1125-1137. doi: 10.1245/s10434-023-14610-0. Epub 2023 Nov 25.
7
Survival Trends in Patients with Small Intestinal Neuroendocrine Tumours-A Cohort Study in Central Norway.挪威中部小肠神经内分泌肿瘤患者的生存趋势——一项队列研究
Cancers (Basel). 2023 Jun 21;15(13):3272. doi: 10.3390/cancers15133272.
8
Fluorescence-guided surgery using methylene blue to improve identification of metastatic small intestinal neuroendocrine tumours.使用亚甲蓝进行荧光引导手术以改善转移性小肠神经内分泌肿瘤的识别。
Br J Surg. 2023 Apr 12;110(5):541-544. doi: 10.1093/bjs/znad043.
9
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort.转移性小肠神经内分泌肿瘤 2 级患者的治疗效果。
Endocr Relat Cancer. 2023 Feb 14;30(3). doi: 10.1530/ERC-22-0316. Print 2023 Mar 1.